TENON MEDICAL INC-28 (TNONW:NASDAQ)
$0.0081 -0.0024 (-22.8571%)
Analysed TENON MEDICAL INC-28 (TNONW:NASDAQ) News Sources
Tenon(R) Medical Reports First Quarter 2026 Financial Results
12-05-2026
yahoo.com
Tenon Medical, Inc. Q1 2026 Earnings Call Summary
13-05-2026
moby.co
Tenon Medical Inc (TNON) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth ...
13-05-2026
yahoo.com
Tenon Medical, Inc. Announces Pricing of $4.2 Million Public Offering
30-06-2026
yahoo.com
WallachBeth Capital Announces Pricing of Tenon Medical, Inc. $4.2 Million Public Offering
30-06-2026
yahoo.com
Tenon Medical, Inc. Announces Closing of $4.2 Million Public Offering
01-07-2026
yahoo.com
WallachBeth Capital Announces Closing of Tenon Medical, Inc. $4.2 Million Public Offering
01-07-2026
yahoo.com
Tenon Medical(R) Announces FDA 510(k) Clearance for Catamaran(R) SI Joint Fusion System
02-07-2026
yahoo.com
Tenon Medical, Inc. Announces Regained Compliance with Nasdaq Stockholders' Equity Requirement
20-07-2026
yahoo.com
Tenon Medical, Inc. Sets Date for Second Quarter 2026 Earnings
30-07-2026
yahoo.com
What is the current price of TENON MEDICAL INC-28 (TNONW:NASDAQ)?
The current price of TENON MEDICAL INC-28 (TNONW:NASDAQ) is $0.0081.
TENON MEDICAL INC-28 (TNONW:NASDAQ) absolute price change since previous trading day?
The absolute price change of TENON MEDICAL INC-28 (TNONW:NASDAQ) since the previous trading day is $-0.0024.
TENON MEDICAL INC-28 (TNONW:NASDAQ) percentage price change since previous trading day?
The percentage price change of TENON MEDICAL INC-28 (TNONW:NASDAQ) since the previous trading day is -22.8571%.
What is the most recent average sentiment score for TENON MEDICAL INC-28 (TNONW:NASDAQ)?
The most recent average sentiment score for TENON MEDICAL INC-28 (TNONW:NASDAQ) is 59 out of 100.
What is the most recent average sentiment for TENON MEDICAL INC-28 (TNONW:NASDAQ)?
The most recent sentiment for TENON MEDICAL INC-28 (TNONW:NASDAQ) is .
SEC-8K** Filing Available For TENON MEDICAL INC-28 (TNONW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.